Erik Skullerud

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France.

Part of IQVIA, Inc., Pygargus AB is a Swedish company that provides market research and consulting services for the pharmaceutical sector. The private company is based in Stockholm, Sweden. The company was founded by Ragnar Linder. Pygargus was acquired by IQVIA, Inc. from Ängshöken AB on December 09, 2013.

Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.

Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia.

Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The private company is based in London, UK.

RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway.

ProTA Therapeutics Pty Ltd. manufactures pharmaceutical products. The company was founded by Mimi Tang on September 23, 2016 and is headquartered in Melbourne, Australia.

Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.

Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia.

Oculo Therapy LLC is an American biotechnology company.

Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The private company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.

Part of Revenio Group Oyj, CERA Technologies Pty Ltd. is a world-leading eye care platform that connects ophthalmology, optometry, primary care, emergency rooms, and patients to share clinical information and enhance referrals, triage, and collaborative care. The private company is based in Melbourne, Australia. The technology enhances collaboration, bridges disconnected data silos, and delivers fast, efficient patient care. The platform is designed to share clinical correspondence securely and instantly between health care professionals, addressing the known challenges in clinical communication between a collaborative care network of health care providers. The company complies with the data protection regulations of HIPAA, the GDPR, and the Australian Privacy Principles. The company was founded in 2015 by Kate Taylor, Jonathan Crowston. Kate Taylor has been the CEO since 2015. CERA Technologies was acquired by Revenio Group Oyj on April 27, 2021 for $14.42 million.

Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl.